Advertisement
Loading...

CeriBell, Inc.

CBLLNASDAQ
Healthcare
Medical - Devices
$16.30
$-0.16(-0.97%)
U.S. Market opens in 37h 51m

CeriBell, Inc. Fundamental Analysis

CeriBell, Inc. (CBLL) shows moderate financial fundamentals with a PE ratio of -10.26, profit margin of -63.51%, and ROE of -38.19%. The company generates $0.1B in annual revenue with strong year-over-year growth of 36.09%.

Key Strengths

Cash Position23.00%
PEG Ratio-0.37
Current Ratio10.30

Areas of Concern

ROE-38.19%
Operating Margin-68.31%
We analyze CBLL's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -39.4/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-39.4/100

We analyze CBLL's fundamental strength across five key dimensions:

Efficiency Score

Weak

CBLL struggles to generate sufficient returns from assets.

ROA > 10%
-33.90%

Valuation Score

Excellent

CBLL trades at attractive valuation levels.

PE < 25
-10.26
PEG Ratio < 2
-0.37

Growth Score

Excellent

CBLL delivers strong and consistent growth momentum.

Revenue Growth > 5%
36.09%
EPS Growth > 10%
56.93%

Financial Health Score

Excellent

CBLL maintains a strong and stable balance sheet.

Debt/Equity < 1
0.16
Current Ratio > 1
10.30

Profitability Score

Weak

CBLL struggles to sustain strong margins.

ROE > 15%
-3818.69%
Net Margin ≥ 15%
-63.51%
Positive Free Cash Flow
No

Key Financial Metrics

Is CBLL Expensive or Cheap?

P/E Ratio

CBLL trades at -10.26 times earnings. This suggests potential undervaluation.

-10.26

PEG Ratio

When adjusting for growth, CBLL's PEG of -0.37 indicates potential undervaluation.

-0.37

Price to Book

The market values CeriBell, Inc. at 4.40 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

4.40

EV/EBITDA

Enterprise value stands at -10.92 times EBITDA. This is generally considered low.

-10.92

How Well Does CBLL Make Money?

Net Profit Margin

For every $100 in sales, CeriBell, Inc. keeps $-63.51 as profit after all expenses.

-63.51%

Operating Margin

Core operations generate -68.31 in profit for every $100 in revenue, before interest and taxes.

-68.31%

ROE

Management delivers $-38.19 in profit for every $100 of shareholder equity.

-38.19%

ROA

CeriBell, Inc. generates $-33.90 in profit for every $100 in assets, demonstrating efficient asset deployment.

-33.90%

Following the Money - Real Cash Generation

Operating Cash Flow

CeriBell, Inc. generates limited operating cash flow of $-49.21M, signaling weaker underlying cash strength.

$-49.21M

Free Cash Flow

CeriBell, Inc. generates weak or negative free cash flow of $-49.96M, restricting financial flexibility.

$-49.96M

FCF Per Share

Each share generates $-1.32 in free cash annually.

$-1.32

FCF Yield

CBLL converts -7.97% of its market value into free cash.

-7.97%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-10.26

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.37

vs 25 benchmark

P/B Ratio

Price to book value ratio

4.40

vs 25 benchmark

P/S Ratio

Price to sales ratio

6.56

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.16

vs 25 benchmark

Current Ratio

Current assets to current liabilities

10.30

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.38

vs 25 benchmark

ROA

Return on assets percentage

-0.34

vs 25 benchmark

ROCE

Return on capital employed

-0.40

vs 25 benchmark

How CBLL Stacks Against Its Sector Peers

MetricCBLL ValueSector AveragePerformance
P/E Ratio-10.2628.62 Better (Cheaper)
ROE-38.19%783.00% Weak
Net Margin-63.51%-48181.00% (disorted) Weak
Debt/Equity0.160.39 Strong (Low Leverage)
Current Ratio10.304.12 Strong Liquidity
ROA-33.90%-21914.00% (disorted) Weak

CBLL outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews CeriBell, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

119.30%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

8.27%

Industry Style: Defensive, Growth, Innovation

Growing

FCF CAGR

18.61%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ